Appointments at Hovione, Agilux, McKesson and CIT – People on the move

By Nick Taylor

- Last updated on GMT

Related tags Management occupations Corporate governance Managing director

Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Hovione, Agilux, McKesson and CIT.

Hovione​ has appointed Terry Lambe​ to its board of directors. Lambe retired in 2008 having worked at Pfizer for 30 years, during which time he was responsible for the construction of active pharmaceutical ingredient facilities in Puerto Rico, the US and Singapore.

Adrian Sheldon ​has been appointed as associate director of in vitro ​ADMET (absorption, distribution, metabolism excretion and toxicology) services at Agilux Laboratories​.

Sheldon joins the contract research organisation (CRO) from Charles River. In his 17 years in the industry Sheldon has also worked at ArQule.

PriceSpective ​has appointed Walter Colasante​ as a vice president (VP) and Sophie Murdoch​ as a director. Both appointees have significant healthcare experience at companies including Novartis, Allergan and Bristol-Myers Squibb.

Ram Nimmagudda ​has been appointed director of new business development at Spherix Incorporated​, a business that provides regulatory consulting services to pharma and biotech.

McKesson Speciality Care Solutions​, a provider of inventory management services to pharma, has appointed Mark Walchirk​ as president. Walchirk joined the McKesson group in 2001 and most recently worked as senior VP and chief operating officer of the pharma division.

Sophie Baratte ​has been appointed as managing director of CIT​ (Centre International de Toxicologie), a European non-clinical CRO. Barette has previously worked Sorin France, Beckman and Johnson & Johnson.

In addition Jean- François Le Bigot​, previously CIT’s chairman and CEO, has become executive president of the business and its holding company Applied Biology Company.

Related topics Markets & Regulations

Related news

Show more

Follow us


View more